• In late April 2026, Ormat Technologies announced that analysts expected the company to report higher year-over-year earnings and revenue for the March 2026 quarter, ahead of its scheduled earnings release on May 6.
• This brighter analyst outlook, reflected in estimates above the broader consensus, underscores growing confidence in Ormat’s near-term earnings power and project pipeline execution.
• With analyst expectations improving ahead of the May 6 earnings report, we’ll now examine how this optimism shapes Ormat’s existing investment narrative.

AI is about to change healthcare. These 33 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.

Ormat Technologies Investment Narrative Recap

To own Ormat, you need to believe in long term demand for reliable, carbon free baseload power and the company’s ability to convert its development pipeline into profitable projects despite high capital needs and policy complexity. The recent uptick in analyst expectations for the March 2026 quarter supports the near term earnings catalyst but does not materially change the key risk that heavy investment and rising leverage could pressure returns if growth or funding conditions soften.

Among recent announcements, Ormat’s plan to issue US$600,000,000 of Series A and US$150,000,000 of Series B convertible senior notes due 2031 stands out as most relevant, since it reinforces how dependent the growth story is on continued access to sizeable, reasonably priced capital. For investors, that financing backdrop will be important context when weighing the improved earnings sentiment ahead of the May 6 report.

Yet behind this brighter earnings outlook, there is a funding and leverage risk that investors should be aware of...

Ormat Technologies' narrative projects $1.3 billion revenue and $200.4 million earnings by 2029.

Uncover how Ormat Technologies' forecasts yield a $127.09 fair value, a 12% upside to its current price.

Exploring Other Perspectives

Three fair value estimates from the Simply Wall St Community cluster between US$111.75 and US$127.09, showing how differently individual investors view Ormat’s prospects. Set against this spread, the company’s heavy capital expenditure needs and rising leverage remind you to weigh optimistic earnings expectations alongside the risk that more expensive funding could pressure future returns.

Explore 3 other fair value estimates on Ormat Technologies - why the stock might be worth as much as 12% more than the current price!

The Verdict Is Yours

Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.

• A great starting point for your Ormat Technologies research is our analysis highlighting 2 key rewards and 1 important warning sign that could impact your investment decision.
• Our free Ormat Technologies research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Ormat Technologies' overall financial health at a glance.

Interested In Other Possibilities?

Right now could be the best entry point. These picks are fresh from our daily scans. Don't delay:

• Capitalize on the AI infrastructure supercycle with our selection of the 37 best 'picks and shovels' of the AI gold rush converting record-breaking demand into massive cash flow.
• Invest in the nuclear renaissance through our list of 91 elite nuclear energy infrastructure plays powering the global AI revolution.
• Outshine the giants: these 18 early-stage AI stocks could fund your retirement.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.